primari
function
respiratori
system
ga
exchang
render
vulner
environment
pathogen
circul
air
physic
cellular
barrier
respiratori
tract
mucos
surfac
util
varieti
strategi
obstruct
microb
entri
physic
barrier
defens
includ
surfac
fluid
replet
antimicrobi
neutral
immunoglobulin
mucu
epitheli
cell
layer
rapidli
beat
cilia
form
near
impenetr
wall
separ
extern
environ
intern
soft
tissu
host
resid
leukocyt
primarili
innat
immun
branch
also
maintain
airway
integr
constant
surveil
mainten
homeostasi
releas
cytokin
growth
factor
unfortun
pathogen
influenza
viru
streptococcu
pneumonia
requir
host
replic
dissemin
prey
respiratori
tract
ideal
environ
caus
sever
damag
host
invas
review
outlin
hostpathogen
interact
influenza
postinfluenza
bacteri
pneumonia
focu
interand
intracellular
crosstalk
import
pulmonari
immun
respons
respiratori
system
divid
upper
nasal
passag
pharynx
larynx
lower
trachea
bronchial
tree
lung
compon
cumul
mucos
surfac
area
exce
entir
length
system
roughli
divid
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
contain
physic
barrier
made
liquid
cell
layer
figur
oneunit
airway
concept
propos
underscor
import
consid
chang
occur
upper
lower
airway
concomitantli
investig
diseas
affect
respiratori
tract
like
rhiniti
asthma
approxim
branch
line
epitheli
cell
make
airway
within
soft
lung
tissu
handl
l
inhal
air
day
place
epitheli
surfac
contact
variou
noxiou
innocu
materi
includ
environment
dissemin
virus
bacteria
figur
cellular
composit
upper
lower
respiratori
tract
serv
primari
barrier
epitheli
cell
ec
span
entir
length
respiratori
tract
rt
line
basal
cell
attach
basement
membran
squamou
ec
make
begin
nasal
end
alveoli
rt
ciliat
noncili
columnar
epithelia
makeup
upper
rt
larg
bronchi
cuboid
epithelia
line
small
bronchi
bronchiol
surfac
liquid
overlay
ec
consist
mucu
secret
mucu
produc
cell
airway
liquid
secret
secretori
cell
neutral
immunoglobulin
antimicrobi
resid
leukocyt
dendrit
cell
cell
innat
lymphoid
cell
line
mucosa
alveolar
macrophag
found
lower
airway
alveoli
bronchial
smooth
muscl
cell
underli
rt
basal
end
provid
structur
support
elast
airway
primari
point
contact
epithelia
respiratori
system
consid
regulatori
point
immun
respons
respiratori
mucosa
made
sever
type
epitheli
cell
secretori
cell
goblet
cell
neuroendocrin
cell
mucos
barrier
multifunct
provid
physic
barrier
secretori
barrier
immun
defens
uniform
upper
lower
respiratori
barrier
compon
ensur
multipl
level
filtrat
air
particl
safeguard
singlelayerthick
alveolar
space
figur
secretori
barrier
consist
mucu
antimicrobi
protein
neutral
antibodi
etc
breach
epitheli
cell
come
contact
invad
environment
pathogen
cell
becom
activ
begin
commun
resid
leukocyt
particip
inflammatori
cascad
repair
mechan
follow
invas
review
discuss
current
understand
barrier
respons
two
major
respiratori
pathogen
influenza
viru
streptococcu
pneumonia
otherwis
healthi
host
influenza
infecti
diseas
caus
influenza
virus
belong
orthomyxovirida
famili
four
genera
influenza
virus
influenza
influenza
b
known
caus
influenza
human
former
greater
propens
caus
sever
diseas
influenza
ill
unit
state
affect
million
person
kill
annual
segment
neg
sens
rna
viru
iav
predispos
genet
mutat
gene
reassort
latter
support
iav
procliv
zoonot
infect
subtyp
iav
base
characterist
surfac
express
glycoprotein
hemagglutinin
ha
neuraminidas
na
also
regul
viral
bind
releas
life
cycl
within
host
cell
although
iav
shown
infect
varieti
cell
type
epitheli
cell
upper
lower
respiratori
tract
primari
target
replic
viru
transmiss
fundament
iav
pathogenesi
establish
new
host
govern
ha
molecul
environment
factor
also
play
import
role
distribut
mucos
secret
larg
small
droplet
droplet
nuclei
contain
infecti
virion
humananim
behavior
iav
reach
mucosa
new
host
util
numer
strategi
overcom
hostil
host
environ
success
infect
pathogenesi
resid
cell
respond
infect
type
type
iii
interferon
ifn
product
respons
continu
process
lead
loss
epitheli
cell
therebi
expos
basement
membran
morpholog
chang
remain
epithelia
compromis
barrier
respons
induc
leaki
junction
protein
inflamm
aberr
repair
process
airway
epithelium
consist
ciliat
noncili
cell
overlaid
two
layer
mucu
figur
bottom
layer
less
viscou
periciliari
liquid
pcl
allow
free
ciliari
movement
top
layer
gellik
mucu
layer
inhal
matter
stick
mucu
layer
also
rich
variou
highli
polymer
mucin
antimicrobi
peptid
neutral
antibodi
etc
serv
biochem
barrier
inhibit
pathogen
penetr
inhal
particl
never
gain
access
pcl
bind
gel
layer
get
brush
upward
mucociliari
escal
similarli
surfact
protein
abund
lower
airway
secret
bind
iav
enhanc
viral
clearanc
viru
attach
respiratori
epithelia
possibl
infecti
virion
bypass
upper
gel
barrier
gain
access
sol
layer
beneath
viral
ha
protein
facilit
entri
cell
bind
sialic
acid
receptor
present
apic
side
epitheli
cell
linkag
sialic
acid
galactos
could
either
recogn
avian
virus
recogn
human
virus
sinc
sialic
acid
receptor
present
heterogen
mix
epitheli
cell
differ
speci
unclear
iav
select
specif
also
bind
sialic
acid
usual
limit
urt
epithelia
receptor
avail
throughout
airway
epitheli
barrier
physic
manifest
barrier
afford
three
type
junction
protein
epithelia
tight
junction
tj
adheren
junction
aj
desmosom
figur
role
tj
wellcharacter
influenza
viru
pathogenesi
three
main
transmembran
protein
occludin
claudin
junction
adhes
molecul
jam
respons
tightli
seal
membran
adjac
cell
within
tj
peripher
membran
protein
zonula
occludin
zo
bind
transmembran
protein
tj
stabil
cytoskeleton
mediat
signal
iav
infect
disrupt
epitheli
barrier
caus
reduc
express
occludin
jam
soon
infect
nonstructur
protein
iav
play
key
role
virul
pdzbind
motif
pbm
bind
pdz
domain
present
tj
protein
destabil
junction
integr
rearrang
occludin
activ
infect
abil
host
cell
commun
one
anoth
essenti
order
warn
surround
cell
threat
initi
immun
respons
figur
variou
strategi
employ
airway
epithelia
purpos
includ
releas
interferon
ifn
cytokin
antimicrobi
peptid
nitric
oxid
recent
describ
extracellular
vesicl
main
viral
countermeasur
epitheli
respons
induct
epitheli
cell
death
infectioninduc
product
type
ifn
known
trigger
express
varieti
deathassoci
molecul
epithelia
includ
fa
trail
receptor
caspas
caus
epitheli
cell
death
earli
phase
infect
releas
proinflammatori
cytokin
initi
inflammasom
activ
iav
lead
pyroptosi
virusmedi
epitheli
cell
death
occur
earli
infect
death
within
h
sinc
cell
death
increas
permeabl
epitheli
layer
product
infect
respiratori
epithelium
detriment
barrier
potenc
addit
infect
epithelia
present
viral
antigenload
mhci
molecul
target
antigenspecif
cell
destruct
major
mechan
viral
clearanc
lung
interestingli
howev
ciliat
alveolar
epitheli
cell
downregul
mhci
evad
cellmedi
death
surviv
iav
infect
showcas
mechan
use
immun
system
reduc
host
patholog
influenza
epitheli
cell
lower
respiratori
tract
termin
alveoli
squamou
type
type
ii
pneumocyt
figur
sinc
cell
primari
site
ga
exchang
bath
thin
layer
fluid
rich
surfact
protein
reduc
surfac
tension
adjoin
capillari
network
lung
one
import
function
alveolar
epithelium
remov
fluid
alveolar
lumen
help
ion
channel
amiloridesensit
epitheli
sodium
channel
enac
present
apic
surfac
pneumocyt
na
katpas
present
basolater
membran
alveolar
epithelia
also
suscept
iav
infect
lead
barrier
destruct
therebi
disrupt
intric
balanc
ion
transport
fluid
mainten
caus
edema
hypoxemia
pneumonia
fact
iav
matrix
protein
inhibit
enac
caus
edema
respiratori
insuffici
influenza
evid
suggest
cumul
downregul
enac
cftr
na
katpas
epitheli
cell
earli
stage
iav
infect
interestingli
type
ifn
releas
epithelia
late
phase
iav
infect
caus
upregul
trail
alveolar
macrophag
am
turn
caus
epitheli
cell
na
katpas
downregul
edema
alter
airway
fluid
dynam
affect
neighbor
cell
infect
therebi
influenc
function
similarli
epitheli
cellderiv
transform
growth
factor
tgf
activ
viral
na
reduc
activ
na
katpas
respiratori
mucos
barrier
contain
sentinel
cell
compris
am
dendrit
cell
dc
tcell
innat
lymphoid
cell
ilc
support
antivir
immun
respons
earli
late
phase
iav
infect
recent
review
us
function
respons
cell
influenza
investig
interact
epithelium
ongo
infect
fulli
explor
indirect
commun
epithelia
resid
leukocyt
mean
cytokin
may
greater
signific
direct
interact
iav
infect
figur
earli
releas
cytokin
infect
epitheli
cell
regul
tone
immun
respons
activ
resid
cell
epitheli
cell
becom
awar
viru
invas
mainli
three
famili
pattern
recognit
receptor
retino
acidinduc
genelik
receptor
rlr
nucleotidebind
domain
leucinerichrepeatcontain
protein
nlr
tolllik
receptor
tlr
stimul
trigger
product
varieti
cytokin
chemokin
includ
ifn
figur
three
type
ifn
type
type
ii
type
iii
import
antivir
defens
iav
type
iii
produc
epithelia
type
ifn
receptor
ifnar
express
varieti
leukocyt
addit
airway
epitheli
cell
aec
allow
respons
sinc
type
iii
ifn
receptor
ifnlr
predominantli
express
aec
respons
cytokin
howev
discoveri
ifnlr
neutrophil
dc
suggest
broad
function
cytokin
respiratori
pathogen
protect
barrier
respons
type
ii
ifn
larg
secret
natur
killer
nk
cell
recruit
cell
respons
iav
infect
signal
local
macrophag
popul
express
receptor
ifngr
promot
phagocytosi
reactiv
burst
product
proinflammatori
cytokin
immedi
follow
iav
infect
am
contribut
first
wave
type
type
iii
ifn
essenti
protect
lrt
viral
progress
dissemin
viru
need
overcom
wave
ifn
establish
success
infect
addit
proinflammatori
cytokin
produc
am
respons
iav
includ
also
contribut
enhanc
viral
clearanc
activ
antivir
defens
mechan
surround
immun
epitheli
cell
howev
sudden
excess
product
cytokin
sometim
trigger
highli
virul
strain
iav
caus
alveolar
hemorrhag
pulmonari
edema
bronchopneumonia
acut
respiratori
distress
syndrom
damag
mucos
epithelia
import
am
stage
respiratori
immun
influenza
highlight
ghoneim
et
al
wherein
virusinduc
deplet
am
lung
left
host
vulner
invad
opportunist
bacteria
mice
defici
am
suscept
sever
influenza
due
increas
infect
type
pneumocyt
diffus
alveolar
damag
one
critic
growth
factor
differenti
prolifer
activ
am
gmcsf
larg
produc
type
ii
alveolar
epitheli
cell
influenza
mice
defici
gmcsf
receptor
increas
morbid
mortal
influenza
similar
anim
devoid
am
figur
macrophag
maintain
environment
homeostasi
remov
apoptot
cell
debri
am
also
import
tissu
repair
phase
follow
activ
infect
iav
efferocytosi
die
epithelia
neutrophil
epitheli
cell
prolifer
repair
influenza
promot
product
hepatocyt
growth
factor
epitheli
cell
tlr
guid
adapt
immun
respons
iav
mold
activ
dc
serv
bridg
innat
adapt
immun
dc
interspers
epitheli
barrier
sampl
inhal
air
dendrit
major
report
investig
function
dc
influenza
focus
interact
immun
effector
recruit
late
phase
immun
respons
therefor
littl
known
interact
dc
mucos
resid
cell
plasmacytoid
dc
pdc
known
produc
high
amount
type
ifn
frontier
immunolog
wwwfrontiersinorg
iav
infect
pathway
human
primari
bronchial
epitheli
cell
enhanc
type
ifn
product
upregul
ifn
respons
gene
pdc
cocultur
showcas
crosstalk
structur
cell
local
immun
cell
cytokin
similar
crosstalk
occur
pdc
am
wherein
pdc
control
number
cytokin
profil
am
airway
epitheli
barrier
also
contain
small
percentag
cell
consid
function
barrier
defens
murin
model
iav
infect
cell
increas
late
phase
diseas
produc
immunoregulatori
cytokin
howev
deplet
cell
impact
viral
clearanc
product
neonat
model
iav
infect
mice
highli
pathogen
iav
directli
activ
cell
induc
upregul
express
enhanc
secret
similarli
cell
produc
respons
iav
trigger
releas
aec
turn
mediat
treg
cell
data
indic
cell
critic
mainten
lung
homeostasi
tissu
repair
viral
clearanc
phase
addit
protect
regul
mucos
barrier
provid
ilc
character
absenc
tand
bcell
receptor
like
tcell
ilc
also
categor
accord
cytokin
product
profil
investig
subset
context
influenza
classic
known
produc
respons
epitheli
cytokin
tslp
infect
wild
type
well
mice
iav
led
ilc
accumul
lung
although
direct
evid
iavmedi
ilc
accumul
depend
aecderiv
cytokin
furthermor
report
iav
infect
induc
am
produc
promot
airway
hyperreact
role
tissu
homeostasi
impli
studi
wherein
ilc
deplet
shown
impact
lung
function
epitheli
integr
tissu
remodel
high
amount
type
type
ii
ifn
produc
earli
phase
iav
infect
shown
inhibit
function
prolifer
convers
defici
lead
host
protect
increas
product
amphiregulin
nktcell
am
also
shown
produc
respons
iav
signal
ilc
produc
increas
level
viral
clearanc
phase
may
help
recruit
eosinophil
airway
mucos
barrier
enhanc
cellular
immun
respons
perhap
necessari
tissu
repair
instanc
virusinduc
inflamm
dysregul
commun
lung
framework
leav
host
vulner
secondari
bacteri
infect
exemplifi
increas
suscept
individu
iav
infect
acquisit
streptococcu
pneumonia
pneumococcu
result
converg
provok
far
greater
morbid
mortal
infect
either
pathogen
alon
host
remain
suscept
pneumonia
infect
even
viru
clear
suggest
compromis
immun
milieu
structur
barrier
contribut
increas
bacteri
pathogenesi
although
iav
enhanc
pneumonia
pathogenesi
directli
instanc
expos
cryptic
bind
site
epitheli
damag
liber
sialic
acid
sialyl
mucin
catabol
pneumonia
influenza
viru
also
modifi
interact
epithelium
inflammatori
compon
creat
environ
subvert
pneumococcu
surfac
express
tlr
epitheli
cell
sens
pneumonia
recognit
numer
bacteri
compon
includ
agonist
type
pilu
peptidoglycan
lipoteicho
acid
bacteri
lipoprotein
agonist
pneumolysin
although
iav
directli
recogn
either
regul
activ
tlr
influenza
shown
enhanc
suscept
secondari
bacteri
infect
increas
signal
iav
pneumonia
coinfect
result
heighten
product
augment
inflamm
morbid
addit
iav
infect
posit
regul
pulmonari
epitheli
cell
recogn
doublestrand
rna
impair
clearanc
pneumonia
lung
follow
activ
poli
c
stimul
also
lead
earli
product
aec
contribut
type
ifn
respons
elicit
influenza
key
factor
host
suscept
secondari
pneumococc
infect
discuss
later
review
crucial
initi
step
pneumococc
pathogenesi
bacteri
adher
respiratori
epithelium
initi
pneumonia
establish
host
colon
nasopharynx
consid
necessari
precursor
pneumococc
diseas
iavinduc
epitheli
cell
death
may
expos
basement
membran
pneumonia
bind
use
shortcut
bloodstream
pneumococcu
surfac
protein
includ
pava
pavb
pfba
pfbb
pepo
pilu
subunit
rgra
abil
bind
basement
membran
compon
fibronectin
laminin
collagen
urt
pneumococci
migrat
lung
establish
symptomat
infect
pneumonia
bacteremia
healthi
individu
wayward
pneumococci
airway
expel
mucociliari
escal
reach
lrt
howev
recent
iav
infect
reduc
veloc
ciliari
beat
caus
death
ciliat
tracheal
cell
provid
pneumococci
opportun
bind
epithelium
observ
earli
h
challeng
mice
addit
increas
access
iav
regul
bind
receptor
pneumonia
epitheli
surfac
figur
numer
virus
includ
iav
increas
preval
host
platelet
activ
factor
receptor
pafr
bind
phosphorylcholin
moieti
figur
continu
mucos
damag
cascad
permit
opportunist
infect
host
recov
virusinduc
damag
lung
mucosa
highli
suscept
streptococcu
pneumonia
infect
possibl
due
expos
bind
partner
host
cell
well
open
barrier
gate
due
signific
loss
epitheli
cell
second
wave
type
ifn
may
help
promot
bacteri
colon
negat
posit
influenc
interleukin
il
recruit
phagocyt
transform
growth
factor
tgf
produc
late
phase
influenza
repair
mechan
may
also
promot
bacteri
adher
mucos
surfac
pneumococc
cell
wall
activ
latent
iav
na
present
airway
influenza
prime
epithelium
bacteri
adher
stimul
cell
upregul
bacteri
receptor
integrin
absenc
signal
iavinfect
epitheli
cell
lose
increas
vulner
pneumococc
colon
although
invas
diseas
arguabl
favor
outcom
extracellular
respiratori
bacterium
like
pneumonia
optim
infect
nt
extend
past
airway
prior
influenza
promot
migrat
lung
bloodstream
homeostat
condit
howev
strict
mainten
tj
cell
epitheli
endotheli
barrier
prevent
pneumococc
migrat
physic
restrict
movement
bacteria
cell
mask
receptor
disrupt
tj
influenza
permit
pneumonia
migrat
airway
bloodstream
pneumococci
also
enter
blood
airway
transmigr
epitheli
endotheli
cell
follow
bind
cell
wall
phosphorylcholin
moieti
host
pafr
pneumococci
intern
receptor
recycl
figur
altern
invas
may
facilit
interact
polymer
immunoglobulin
receptor
pigr
pneumococc
cbpa
rrga
pillu
subunit
latter
involv
pigrmedi
invas
brain
microvascular
endothelium
mechan
may
also
applic
nasopharyng
epitheli
cell
level
epitheli
surfac
activ
marker
associ
bacteri
defens
epcam
hladr
alter
pneumococc
colon
urt
bacteri
uptak
pharyng
epitheli
cell
associ
straindepend
chang
transcriptom
invas
strain
like
induc
upregul
gene
compar
strain
typic
associ
carriag
regul
pathway
common
colon
diseasecaus
pneumonia
strain
associ
innat
immun
respons
map
kinas
activ
toll
receptor
cytokin
signal
correspond
hypersecret
furthermor
profound
chang
transcriptom
follow
pneumococc
infect
coincid
clearanc
colon
bacteria
experiment
human
pneumococc
carriag
model
suggest
transmigr
bloodstream
may
unintent
consequ
innat
resolut
pneumococc
carriag
pneumococc
infect
produc
tcell
predomin
sourc
pneumococc
pneumonia
later
h
tcell
h
respons
mucos
epithelium
particip
pneumococc
clearanc
nasopharynx
lung
recruit
monocyt
neutrophil
offer
protect
reinfect
howev
induct
type
ifn
influenza
inhibit
h
defens
secondari
pneumococc
infect
suppress
express
pulmonari
tcell
result
impair
recruit
phagocyt
figur
furthermor
type
ifn
also
reduc
product
lead
fewer
recruit
macrophag
airway
concurr
pneumococc
infect
increas
colon
urt
mice
recov
influenza
also
unabl
mount
effect
kc
respons
follow
infect
pneumonia
stunt
neutrophil
recruit
macrophag
neutrophil
major
compon
innat
cell
respons
extracellular
bacteria
control
bacteri
infect
phagocytosi
direct
kill
recruitmentactiv
inflammatori
cell
earli
induct
type
ifn
am
dc
aec
fundament
import
antivir
immun
influenza
detriment
pneumococc
infect
disrupt
recruit
cell
import
control
bacteri
outgrowth
accordingli
mice
lack
ifnar
signal
fewer
bacteria
lung
lower
level
bacteremia
better
outcom
follow
iav
pneumonia
coinfect
mononuclear
cell
neutrophil
recruit
airway
influenza
contribut
damag
respiratori
epithelium
recruit
macrophag
caus
signific
traildepend
apoptosi
leakag
aec
increas
recruit
macrophag
parallel
loss
am
hamper
host
abil
restrict
secondari
pneumococc
infect
rapidli
progress
pneumonia
neutrophil
extracellular
trap
releas
respons
iav
potenti
damag
epithelium
ineffect
secondari
pneumococc
infect
pneumococci
enter
postinfluenza
rt
present
environ
harbor
reduc
number
resid
macrophag
also
encount
lymphocyt
state
immunolog
exhaust
unabl
appropri
respond
infect
type
ifn
produc
epitheli
cell
other
iav
infect
caus
polyclon
activ
tand
bcell
despit
cell
return
baselin
state
sever
day
infect
prevent
activ
subsequ
exposur
type
ifn
state
exhaust
last
sever
day
host
particularli
vulner
secondari
infect
iav
infect
sole
good
news
pneumonia
host
respons
viral
infect
also
promot
protect
secondari
bacteri
infect
instanc
exampl
type
ifn
disrupt
cell
recruit
pneumococc
infect
induct
also
restrict
pneumonia
pathogenesi
upregul
express
tj
protein
claudin
claudin
claudin
ecadherin
decreas
pafr
level
epitheli
endotheli
lung
cell
adenosin
present
extracellular
environ
stress
inflamm
shown
releas
respiratori
epitheli
cell
amongst
other
iav
infect
mice
atp
level
airway
elev
due
increas
de
novo
synthesi
poor
alveolar
fluid
clearanc
sequenti
hydrolyz
gener
adenosin
activ
receptor
extracellular
adenosin
decreas
express
pafr
lung
epithelium
promot
recruit
neutrophil
monocyt
lymphocyt
influenza
contribut
protect
secondari
infect
pneumonia
produc
influenza
pulmonari
nk
cell
cell
bind
aec
endotheli
cell
interact
antagon
solubl
form
human
endotheli
cell
respond
increas
product
chemoattract
cell
involv
resolut
bacteri
infect
monocyt
dendrit
cell
lymphocyt
critic
epitheli
repair
follow
infect
absenc
mice
sustain
significantli
higher
lung
injuri
loss
airway
epitheli
integr
subleth
iav
infect
follow
pneumonia
coinfect
administr
exogen
mice
influenza
caus
upregul
gene
encod
protein
involv
cellcel
adhes
encod
claudin
protocadherin
respect
lung
reduc
system
dissemin
pneumonia
secondari
bacteri
infect
interestingli
although
mice
lack
decoy
significantli
reduc
bacteri
outgrowth
lung
coinfect
dissemin
unaffect
mucoepitheli
barrier
one
import
host
respiratori
defens
encroach
bacteri
pathogen
howev
local
damag
inflammatori
milieu
occas
influenza
compromis
efficaci
physic
barrier
interact
compon
inflammatori
repertoir
interest
mani
aspect
postinfluenza
lung
microenviron
known
exacerb
pneumococc
infect
also
target
pneumonia
order
avoid
immun
clearanc
establish
infect
pneumococc
cytotoxin
pneumolysin
disrupt
tj
reduc
cilia
organ
preval
neglig
impact
ciliari
beat
addit
pneumonia
caus
cell
damag
loss
planar
epitheli
architectur
mucos
surfac
pneumococci
abl
evad
neutrophil
express
polysaccharid
capsul
also
physic
reduc
deposit
complement
antibodi
molecular
mimicri
wherein
bacteri
phosphorylcholin
moieti
bind
pafr
prevent
paf
initi
neutrophil
phagocytosi
bactericid
activ
respect
iav
perfect
partner
pneumonia
provid
compromis
mucos
epitheli
barrier
permiss
establish
infect
time
dampen
antibacteri
host
respons
report
vivo
model
coinfect
anim
commonli
challeng
pneumonia
day
iav
correspond
pronounc
chang
morbid
mortal
howev
influenza
still
predispos
mice
pneumonia
infect
later
time
challeng
clinic
posit
correl
influenza
sever
pneumococc
pneumonia
week
separ
two
infecti
agent
suggest
iav
impart
long
term
effect
host
predict
iav
caus
profound
destruct
type
ii
pneumocyt
caus
impair
regener
diseas
resolut
also
infect
epcam
high
low
integrin
high
epitheli
stemprogenitor
cell
therebi
reduc
renew
cell
respiratori
barrier
influenza
preced
pneumococc
infect
may
also
affect
immun
respons
reinfect
pneumonia
h
immun
promot
acceler
bacteri
clearanc
urt
follow
secondari
infect
pneumonia
consid
type
ifn
inhibit
h
activ
thu
gener
memori
cell
influenza
may
prevent
h
protect
subsequ
infect
heterolog
pneumococc
serotyp
clinic
influenza
diseas
commonli
manifest
uncompl
upper
respiratori
infect
fever
malais
headach
cough
myalgia
symptomat
treatment
consist
counter
antiinflammatori
pain
medic
mainstay
current
influenza
antivir
medic
na
inhibitor
oseltamivir
zanamivir
peramivir
sialic
acid
cleavag
activ
na
requir
releas
virion
infect
epitheli
cell
also
facilit
migrat
epitheli
mucin
layer
benefit
na
inhibitor
primarili
restrict
uncompl
diseas
treatment
institut
within
first
h
symptom
modest
reduct
durat
ill
recent
approv
antivir
baloxavir
marboxil
act
select
inhibitor
influenza
cap
endonucleas
similar
na
inhibitor
baloxavir
marboxil
proven
benefit
earli
treatment
uncompl
influenza
case
addit
observ
rapid
develop
resist
outpati
trial
rais
concern
longterm
usag
nitazoxanid
antiprotozo
drug
use
treat
cryptosporidium
giardia
infect
vitro
data
demonstr
antivir
activ
influenza
b
strain
act
inhibit
influenza
ha
traffick
epitheli
endoplasm
reticulum
golgi
apparatu
prevent
matur
block
ha
termin
glycosyl
phase
trial
nitazoxanid
uncompl
influenza
welltoler
show
reduc
symptom
viral
load
random
placebocontrol
phase
iii
trial
complet
march
remain
current
unpublish
approv
drug
primari
target
viru
also
affect
local
immun
respons
viru
initi
respiratori
epitheli
cell
detail
sever
influenza
lead
respiratori
failur
acut
respiratori
distress
syndrom
ard
mortal
rate
epitheli
barrier
disrupt
pronounc
pulmonari
edema
hallmark
ard
sinc
direct
treatment
counteract
effect
present
care
remain
predominantli
support
mechan
ventil
secret
clearanc
extracorpor
membran
oxygen
necessari
evid
need
addit
influenza
therapi
particularli
hospit
patient
sever
diseas
primari
site
infect
respiratori
epithelium
repres
import
area
focu
diseas
treatment
fludas
recombin
sialidas
cleav
sialic
acid
receptor
iav
aec
prevent
viral
entri
cell
preclin
trial
show
broad
vitro
influenza
antivir
activ
protect
effect
anim
model
phase
ii
trial
fludas
welltoler
led
decreas
viral
load
shed
howev
fludas
liber
sialic
acid
rais
interest
question
regard
pneumonia
coinfect
sialic
acid
shown
facilit
colon
iav
infect
pneumonia
infect
fludasetr
mice
influenza
alter
bacteri
colon
mortal
effect
continu
fludas
treatment
concurr
pneumonia
colonizationinfect
fulli
elucid
detail
late
influenza
infect
lead
signific
trailmedi
apoptosi
contribut
continu
pathogenesi
even
viral
load
subsid
preclin
data
show
iavinfect
mice
treat
antitrail
sera
attenu
lung
epitheli
apoptosi
lung
leakag
increas
surviv
iav
infect
moreov
antitrail
treatment
abl
reduc
bacteri
load
protect
pneumonia
coinfect
altern
inhibitor
develop
treat
certain
cancer
antiapoptot
suggest
potenti
treatment
influenza
vitro
data
show
decreas
viral
replic
spread
due
agent
mainten
epitheli
barrier
induct
antivir
mechan
involv
ifn
signal
influenza
interferonlambda
treatment
mice
lead
reduc
viral
load
improv
surviv
without
induc
proinflammatori
cytokin
releas
anoth
studi
treatment
abl
prevent
viral
spread
nasal
passag
lung
confer
resist
iav
mice
day
howev
model
iav
methicillin
resist
staphylococcu
aureusstreptococc
superinfect
increas
iavinfect
mice
lead
increas
bacteri
burden
due
decreas
bacteri
uptak
neutrophil
remain
seen
potenti
therapi
prove
benefici
treat
human
influenza
corticosteroid
routin
use
antiinflammatori
properti
chronic
condit
asthma
chronic
obstruct
pulmonari
diseas
copd
influenza
ard
manifest
sever
proinflammatori
respons
appropri
blunt
respons
may
benefici
clinic
ill
addit
corticosteroid
direct
effect
respiratori
epithelium
may
protect
vitro
steroid
treatment
led
decreas
epitheli
permeabl
action
occludin
recruit
tj
howev
corticosteroid
found
benefit
patient
iav
infect
cochran
review
anoth
metaanalysi
highlight
signific
heterogen
publish
studi
show
benefit
instead
trend
toward
increas
mortal
therefor
efficaci
therapi
influenza
remain
controversi
pneumonia
typic
suscept
mani
commonli
use
antibiot
like
penicillin
howev
resist
multipl
antibiot
class
grow
current
vaccin
pneumococc
diseas
includ
pneumococc
conjug
polysaccharid
vaccin
despit
broad
immun
practic
howev
invas
pneumococc
diseas
remain
common
high
morbid
mortal
similar
influenza
target
microbehost
interact
could
provid
novel
treatment
strategi
pneumococc
diseas
one
exampl
scarboxymethylcystein
scmc
mucolyt
agent
use
copd
shown
inhibit
adher
pharyng
alveolar
epithelia
mucos
organ
system
larg
surfac
area
unremit
exposur
extern
environ
protect
respiratori
barrier
utmost
import
human
health
sinc
barrier
breach
necessari
first
step
environment
pathogen
gain
foothold
rt
maintain
integr
mucos
barrier
focu
point
host
defens
redund
mechanismspathway
may
util
ensur
subsist
herein
review
find
pertain
crosstalk
structur
cell
local
leukocyt
play
role
immun
defens
iav
pneumonia
although
cover
endogen
microbiom
like
play
import
role
mediat
pulmonari
immun
respons
infect
crosstalk
interfac
microbi
pathogen
human
host
epithelium
present
multipl
opportun
develop
clinic
relev
therapi
target
host
mechan
may
provid
less
opportun
emerg
pathogen
resist
use
combin
direct
antimicrobi
medic
may
prove
superior
monotherapi
pathogen
evolv
imper
addit
inform
garner
interact
occur
host
cell
agent
well
cellcel
crosstalk
order
discov
effect
therapeut
strategi
overcom
infect
mucos
barrier
breach
also
import
determin
primari
mechan
relat
individu
underli
chronic
lung
diseas
asthma
copd
interstiti
pulmonari
fibrosi
immun
structur
architectur
well
microbiom
host
fundament
differ
like
lead
alter
defens
mechan
respiratori
infect
author
particip
write
edit
paper
approv
final
submiss
figur
drawn
figur
mt
figur
